1. Abcam (n.d.) Cancer immunotherapy and the PD1/PDL1 checkpoint pathway. https://www.abcam.com/cancer/cancer-immunotherapy-and-the-pd1pdl1-pathway. Accessed 8 July 2020
2. Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742–768. https://doi.org/10.1016/j.neuron.2018.01.021
3. Bertoletti A, Le Bert N (2018) Immunotherapy for chronic hepatitis B virus infection. Gut Liver 12(5):497–507
4. Biotechnolgy Forum (n.d.) Recombinant cytokine therapy for immune and inflammatory disorders. https://www.biotechnologyforums.com/thread-1875.html. Accessed 16 Oct 2019
5. Brunton LL, Lazo JS, Parker KL (1992) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York